Side-by-side comparison of AI visibility scores, market position, and capabilities
Cloud veterinary practice management covering records, scheduling, invoicing, and pharmacy for small-animal clinics. El Segundo CA; developed by Covetrus as the cloud-native complement to legacy AVImark;
eVetPractice is an El Segundo, California-based cloud-based veterinary practice management software that provides independent veterinary clinics with scheduling, electronic medical records, treatment tracking, invoicing, pharmacy management, and client communication in a single web-based platform. Developed by Covetrus, eVetPractice represents the company's cloud-native veterinary practice management offering alongside its legacy AVImark on-premise system, targeting practices ready to move to a browser-based system without the hardware and IT maintenance overhead of on-premise software. The platform is designed for small-animal general practices and emergency hospitals, with clinical templates and workflows appropriate for companion animal medicine.\n\neVetPractice's pharmacy management module is a notable capability, allowing veterinary practices to manage in-clinic medication dispensing, track controlled substance logs, and connect to online pharmacy fulfillment through Covetrus's online pharmacy network. This pharmaceutical connectivity aligns with Covetrus's broader strategy of integrating its animal health distribution and pharmacy businesses with its practice management software. Practices using eVetPractice can process prescription refill requests and manage client prescription histories within the same system used for scheduling and medical records, reducing the context-switching that comes with managing separate pharmacy and practice management platforms.\n\neVetPractice competes with Shepherd, Digitail, ezyVet, and the modernized versions of legacy systems in the cloud veterinary practice management market. The company's positioning within Covetrus gives it integration advantages with the broader Covetrus ecosystem including diagnostic imaging, laboratory connectivity, and prescription management, but also means its development roadmap is influenced by the priorities of a large animal health distributor rather than solely by independent veterinary practice needs. eVetPractice serves practices primarily in the United States with a focus on the independent practice segment.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.